"A simple count of nasal hairs, initially recognized with a humorous award, has revealed a critical baseline for understanding the health impacts of hair loss conditions like alopecia areata, highlighting the nose’s often-overlooked role as a vital air filter."
While the quest to quantify the exact number of hairs within the human nose might seem like an unusual pursuit, this seemingly trivial endeavor has yielded significant insights into respiratory health. Initially garnering attention with an Ig Nobel Prize, the research into nasal hair density has evolved into a serious scientific investigation, providing a crucial baseline for understanding the implications of conditions like alopecia areata. By establishing a typical count, researchers are now better equipped to assess the impact of hair loss on the nose’s protective functions and to evaluate the efficacy of emerging treatments.
A Precise Count for a Vital Function
For years, the precise number of hairs residing within the intricate chambers of the human nose remained a mystery, with no definitive published data available. This knowledge gap prompted a team of researchers at the University of California, Irvine (UC Irvine) to embark on a meticulous, albeit unconventional, study. Utilizing 20 donated cadavers – 10 male and 10 female – from the university’s medical school, the team, led by dermatologist Natasha Atanaskova Mesinkovska, painstakingly counted every single hair in each nostril. Their efforts, spanning across the upper, lateral, and lower portions of the nasal cavity, aimed to establish a reliable average.
The results of this detailed examination were remarkably consistent. Published initially as an abstract in the Journal of the American Academy of Dermatology in 2020 and later as a research letter in the International Journal of Dermatology, the study revealed an average of approximately 120 to 122 hairs per nostril. The length of these nasal hairs typically ranged between 0.81 and 1.035 centimeters. A particularly noteworthy finding, highlighted by the Ig Nobel citation, was the near-equal distribution of hairs between the left and right nostrils, suggesting a biological symmetry in this essential facial feature. While the study’s sample size was limited and comprised cadavers, thus potentially not reflecting variations across different ages, ethnicities, or living tissue, it provided the first concrete quantitative baseline for human nasal hair. This baseline, though initially awarded the 2023 Ig Nobel Prize in Medicine, underscored the scientific community’s acknowledgment of its foundational importance.
The nose’s prominence in Ig Nobel lore continued, with the 2026 Ig Nobel Medicine Prize, awarded in Zurich, posthumously honoring Japanese physician Tokuji Unno for his 1977 aerodynamic study on the mechanics of nose-blowing. These seemingly whimsical accolades, however, frame a serious underlying scientific purpose for the nasal hair count.
The Serious Rationale: Alopecia Areata and Nasal Defense
The impetus behind the UC Irvine team’s meticulous nose-hair count stemmed from a desire to better understand the health challenges faced by patients suffering from alopecia areata. This autoimmune condition is characterized by the immune system mistakenly attacking hair follicles, leading to hair loss. In its most severe form, known as alopecia universalis, individuals can experience the complete loss of body hair, including the crucial hairs within the nasal passages.
Patients afflicted with alopecia areata, particularly those experiencing widespread hair loss, frequently report an increased incidence of upper respiratory infections, allergies, and persistent nasal dryness. The researchers hypothesized that the absence of nasal hairs – the body’s initial line of defense – leaves these individuals more vulnerable to inhaling airborne allergens and infectious particles. Before clinicians and researchers could effectively measure what is lost in such conditions, it was imperative to first establish what constitutes a "normal" nasal hair count. The cadaver study provided precisely this essential baseline, a critical piece of information for future clinical research and patient care.
Nasal Hairs: The Body’s Unsung Air Filter
Medically termed vibrissae, nasal hairs play a vital role in filtering the air we breathe. Their primary function is to trap larger airborne particles, such as dust, pollen, and microorganisms, preventing them from traveling further down the respiratory tract into the lungs. The density of these hairs is believed to be a significant factor in their efficacy as an air filter.
Supporting this notion, a 2011 study published in the International Archives of Allergy and Immunology investigated the link between nasal hair density and asthma in 233 individuals with seasonal allergies. The research found a notable correlation: asthma was more prevalent among participants with sparse nasal hair. Approximately 44.7% of patients with little or no nasal hair reported having asthma, in stark contrast to the 16.7% of those with dense nasal hair. While this study established an association, it is important to note that it did not prove causation. Other contributing factors, such as genetic predisposition or the overall severity of an individual’s allergies, could also play a role in the observed differences. Nevertheless, the findings suggest that a robust presence of nasal hairs may offer a degree of protection against respiratory ailments.
For the general population, the practical implications of this research are relatively modest. Ear, nose, and throat specialists generally advise that trimming visible nose hairs is acceptable. However, they caution against plucking or waxing, as these methods can lead to complications such as infected follicles or ingrown hairs, as explained by an otolaryngologist at Ohio State Wexner Medical Center.
Bridging the Gap: Alopecia Drug Trials and Nasal Hair Monitoring
The landscape of treatment for severe alopecia areata has seen significant advancements in recent years, particularly with the development of a class of drugs known as JAK inhibitors. In July 2024, the U.S. Food and Drug Administration (FDA) approved deuruxolitinib (marketed as Leqselvi) for adult patients diagnosed with severe alopecia areata. Dr. Mesinkovska herself was a co-author of the THRIVE-AA1 phase 3 trial for this drug. This extensive trial, which enrolled 706 adults with at least 50% scalp hair loss across 72 sites in the United States, Canada, and Europe between 2020 and 2022, reported its results in the Journal of the American Academy of Dermatology in 2024.
Intriguingly, nasal hair has become an observed parameter in some of these crucial alopecia research efforts. A statistical analysis plan for a separate deuruxolitinib study, filed on ClinicalTrials.gov, specifically directed examiners to document the presence or absence of nasal hair during full physical examinations and to summarize these findings at various study intervals. While the primary measure of success in these trials remains scalp hair regrowth, the inclusion of nasal hair monitoring signifies a growing clinical awareness of hair loss beyond the scalp. This attention suggests that researchers and clinicians are recognizing the broader implications of hair loss conditions and are beginning to investigate the restoration of these often-overlooked protective barriers.
The critical question that remains unanswered is whether the regrowth of nasal hair, stimulated by these new treatments, effectively restores the protective function against allergens and infections. Addressing this will necessitate well-designed studies involving living patients, leveraging the baseline data established by the UC Irvine cadaver count. Such future research will be instrumental in understanding the full therapeutic potential of treatments for alopecia areata and their impact on overall respiratory well-being.
Individuals diagnosed with alopecia areata who experience recurrent sinus infections, persistent nasal dryness, or frequent allergy flares are strongly encouraged to discuss these symptoms with their dermatologist or primary care physician. These observations can provide valuable insights for their medical team and may inform treatment strategies.
Key Questions Answered
How many hairs are in each nostril?
The UC Irvine cadaver study found an average of roughly 120 hairs per nostril, with the left and right sides showing near-equal counts.
Why did researchers count nose hairs?
The primary motivation was to establish a baseline understanding of normal nasal hair density, which is crucial for assessing what patients with alopecia areata lose when the disease affects their nasal passages.
Does nose hair protect against allergies?
Nasal hairs act as a natural filter, trapping airborne particles. A 2011 study indicated a correlation between sparse nasal hair and higher rates of asthma in individuals with allergies, though it did not establish a direct causal link.
Is it safe to remove nose hair?
Trimming visible nose hairs is generally considered safe. However, plucking or waxing carries a risk of ingrown hairs or infections of the hair follicle.
Can alopecia treatments regrow nose hair?
Some clinical trials for JAK inhibitor drugs used to treat alopecia are now tracking nasal hair. However, it is not yet definitively known how frequently it returns or if its regrowth restores its protective functions.
